Physician profile
Brian J Schuster
NPI 1114236882
$5,870.76
in general payments reported to CMS, 2019-2025
44 companies · $1,233 in 2025
The $1,233 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $868 · 2022: $1,599 · 2023: $1,079 · 2024: $1,092 · 2025: $1,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,201 · Education: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,201.17 |
| Education | $203.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,169.44 | 2021-2025 | Xtandi, Myrbetriq, Veozah |
| Dendreon Pharmaceuticals LLC | $641.19 | 2021-2025 | Provenge |
| Abbvie INC. | $487.84 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $487.19 | 2021-2025 | |
| Janssen Biotech, INC. | $307.59 | 2021-2025 | Erleada |
| Blue Earth Diagnostics | $260.82 | 2021-2025 | Posluma |
| Novartis Pharmaceuticals Corporation | $183.44 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $182.58 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Accord Healthcare, INC. | $172.44 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $164.54 | 2021-2024 | Prolaris |
| Progenics Pharmaceuticals, INC. | $120.54 | 2021-2025 | Pylarify |
| Antares Pharma, INC. | $119.65 | 2021-2023 | Tlando, Xyosted, Nocdurna |
| Endo Pharmaceuticals INC. | $118.30 | 2021-2023 | Xiaflex, Aveed, Edex |
| Astrazeneca Pharmaceuticals LP | $108.72 | 2021-2025 | Imfinzi |
| Coloplast Corp | $93.31 | 2021-2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Schuster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.